1. Home
  2. RETO vs UBX Comparison

RETO vs UBX Comparison

Compare RETO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RETO
  • UBX
  • Stock Information
  • Founded
  • RETO 1999
  • UBX 2009
  • Country
  • RETO China
  • UBX United States
  • Employees
  • RETO N/A
  • UBX N/A
  • Industry
  • RETO Multi-Sector Companies
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RETO Consumer Discretionary
  • UBX Health Care
  • Exchange
  • RETO Nasdaq
  • UBX Nasdaq
  • Market Cap
  • RETO 19.9M
  • UBX 16.5M
  • IPO Year
  • RETO 2017
  • UBX 2018
  • Fundamental
  • Price
  • RETO $0.91
  • UBX $1.73
  • Analyst Decision
  • RETO
  • UBX Strong Buy
  • Analyst Count
  • RETO 0
  • UBX 2
  • Target Price
  • RETO N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • RETO 16.2K
  • UBX 303.9K
  • Earning Date
  • RETO 10-28-2024
  • UBX 11-04-2024
  • Dividend Yield
  • RETO N/A
  • UBX N/A
  • EPS Growth
  • RETO N/A
  • UBX N/A
  • EPS
  • RETO N/A
  • UBX N/A
  • Revenue
  • RETO $3,841,142.00
  • UBX N/A
  • Revenue This Year
  • RETO N/A
  • UBX N/A
  • Revenue Next Year
  • RETO N/A
  • UBX $33.62
  • P/E Ratio
  • RETO N/A
  • UBX N/A
  • Revenue Growth
  • RETO N/A
  • UBX N/A
  • 52 Week Low
  • RETO $0.84
  • UBX $0.94
  • 52 Week High
  • RETO $5.00
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • RETO 47.58
  • UBX 63.32
  • Support Level
  • RETO $0.84
  • UBX $1.56
  • Resistance Level
  • RETO $0.92
  • UBX $1.85
  • Average True Range (ATR)
  • RETO 0.05
  • UBX 0.22
  • MACD
  • RETO 0.00
  • UBX 0.05
  • Stochastic Oscillator
  • RETO 64.60
  • UBX 75.96

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: